Humana Inc. (HUM)
NYSE: HUMHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:03 PM ET · Delayed 15 min
HUM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $46.84B
- P/E (TTM)
- 38.05
- Forward P/E
- 21.06
- EPS (TTM)
- $10.25
- Dividend yield
- 0.91% ($3.54)
- Ex-dividend date
- Jun 26, 2026
- 52-week range
- 163.11 – 462.87
- Day range
- 387.83 – 401.87
- Volume / Avg
- 2.31M / 1.46M
- Beta
- —
- Shares outstanding
- 120.10M
52-week range
HUM stock today
On Nov 20, HUM ended the session at $390.00, adding $10.00 (2.63%), versus the S&P 500's 3.70% decline. At this level, HUM sits in the middle of its 52-week range of $163.11 to $462.87: 15.7% below the high, set on Nov 16, 2026 and 139.1% above the low. HUM is up 52.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 71.7%.
At 38.0x trailing earnings, Humana trades above the peer-group median of 25.7x. Its forward P/E of 21.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Humana pays an annual dividend of $3.54 per share, a 0.91% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Humana
Company profileHumana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. James A. Rechtin M.B.A.
- Headquarters
- Louisville, KY
- Employees
- 67,060
- Website
- humana.com
Financial highlights
Full financialsIn fiscal 2025, Humana generated $129.66 billion in revenue, up 10.1% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $1.19 billion (-1.6% year over year), for a net margin of 0.9% versus a median of 3.0% in the prior 5 years. Operating margin was 2.1%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Growth | +10.11% | +10.70% | +14.54% | +11.81% | +7.66% |
| Net income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| EPS (diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Analyst forecast
ForecastConsensus (26 analysts)
buy
Avg. price target
$510.83+30.98%
- Strong buy 5
- Buy 14
- Hold 6
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 6, 2026
- EPS actual vs est.
- $1.33 vs $-1.03
- Surprise
- +229.13%
Dividends
Dividend history- Annual dividend
- $3.54
- Dividend yield
- 0.91%
- Last payment
- $0.885
- Ex-dividend date
- Jun 26, 2026
HUM news
All HUM news- Friday's ETF Movers: IHF, AISNasdaqEVH, HUM, COHR, WDC
- S&P 500 Movers: SNDK, HONIVNasdaqSNDK, LITE, HUM
- TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlookInvesting.comUNH, HUM
- TD Cowen backs UnitedHealth & Humana with buy upgrades, shares riseSeeking AlphaUNH, HUM
- Should Value Investors Buy Humana (HUM) Stock?Nasdaq
- Humana and Sprouts Farmers Market have been highlighted as Zacks Bull and Bear of the DayNasdaqHUM, FTNT, PANW, SFM
- Bull of the Day: Humana (HUM)Nasdaq
- Humana: The Proposed CRUSH Rule Creates A Buying OpportunitySeeking Alpha
Humana peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NTRANatera Inc. | 273.40 | -5.70% | $39.64B | vs HUM |
| CNCCentene Corporation | 63.78 | -2.74% | $31.58B | vs HUM |
| LHLabcorp Holdings Inc. | 367.13 | -0.47% | $29.81B | vs HUM |
| ILMNIllumina Inc. | 192.82 | -3.90% | $29.15B | vs HUM |
| DGXQuest Diagnostics Incorporated | 258.28 | -0.31% | $28.42B | vs HUM |
| CIThe Cigna Group | 270.90 | -0.78% | $71.38B | vs HUM |
| GHGuardant Health Inc. | 145.83 | +0.16% | $19.73B | vs HUM |
| MOHMolina Healthcare Inc | 198.39 | -2.43% | $10.36B | vs HUM |
Indexes, lists and sector
Humana stock FAQ
What is Humana's stock price today?
HUM last traded at $390.00 as of Nov 20, 4:03 PM EST, up 2.63% on the day. Prices are delayed at least 15 minutes.
Does Humana pay a dividend?
Yes. Humana pays $3.54 per share annually, a 0.91% yield. The most recent dividend of $0.885 had an ex-dividend date of Jun 26, 2026.
What is HUM's P/E ratio?
HUM trades at a trailing P/E ratio of 38.05 and a forward P/E of 21.06, compared with a median of 25.7 for its closest peers.
Is Humana in the S&P 500?
Yes. Humana (HUM) is a constituent of the S&P 500 index.
Who is Humana's CEO?
Mr. James A. Rechtin M.B.A. is the chief executive officer of Humana Inc., which has about 67,060 employees.
Has HUM ever split its stock?
Yes. The most recent HUM stock split was a 3-for-2 split on Aug 1, 1991, one of 4 splits on record.
What is the HUM 52-week high?
The 52-week high for HUM is $462.87 and the 52-week low is $163.11. The stock is currently 15.7% below its high.